This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pneumonia is a lung infection that can be caused by viruses, bacteria or fungi and can result in millions of hospitalizations and deaths annually. These antibiotics target bacteria through mechanisms distinct from traditional antibiotics, thus helping to reduce the impact of resistant strains.
A study published in Nature on July 30, 2020 states that good bacteria living in our gut can do much more than just help digest food and boost our immune system. According to studies conducted by researchers at Cincinnati Children’s Hospital, the bacteria can help heal damaged intestinal tissues.
If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the lifesciences. Here is a look at some lifescience trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.
Xtalks is taking a look at some of the major stories and innovations of the year in the lifesciences, many of which were driven by new, emerging and improved technologies. The year 2021 was all about continuing innovations in the lifesciences. LifeScience Innovations: Malaria and Influenza Vaccines.
Before the Covid-19 pandemic, government-led investment and engagement in lifesciences was relatively restricted worldwide, with the industry mostly funded via private investment. AMR occurs when disease-causing bacteria become resistant or immune to the antibiotics used to treat them.
Co-led by new investors the AMR Action Fund and AXA IM Alts, the investment syndicate also included existing investors Reimagined Ventures, the Bill & Melinda Gates Foundation, Atlantic Neptune, Fiscus Ventures, PEAK6 and Skyviews LifeScience.
Increasing research into the gut microbiome has revealed new and emerging roles for the ‘good bacteria’ in our bodies, with the latest being a new study that shows how they can help the immune system attack cancer cells. The findings were published in the journal Science.
In a landmark study of airborne microorganisms from ground level up to 3,500 metres, scientists from the Singapore Centre for Environmental LifeSciences Engineering (SCELSE) at Nanyang Technological University, Singapore (NTU Singapore) have found that bacteria and fungi populate the planet’s lower atmosphere in very specific ways and if changed, (..)
Membrane-localized phage proteins may also help revitalize, enhance existing antibiotics A study from the Center for Phage Technology, part of Texas A&M’s College of Agriculture and LifeSciences and Texas A&M AgriLife Research, shows how the “hidden” genes in bacteriophages — types of viruses that infect and destroy (..)
Charpentier – currently at the Max Planck Unit for the Science of Pathogens in Germany – and Doudna of the University of California, Berkeley (pictured left to right), are the first two women to share the prize awarded by the Royal Swedish Academy of Sciences. — The Nobel Prize (@NobelPrize) October 7, 2020.
Research involving rats has identified a mechanistic link between high sugar consumption and impaired learning and memory later in life that involves a specific genus of gut bacteria. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. How Sugar May Impair Brain Development in Children.
Researchers from the Institute of Biotechnology at the LifeSciences Center of Vilnius University – Dalia Smalakyte, Audrone Rukšenaite, Dr Giedrius Sasnauskas, Dr Giedre Tamulaitiene, and Dr Gintautas Tamulaitis – have revealed the structure of the CRISPR-Cas "protein scissors" found in bacteria and provided mechanistic details on how they function. (..)
Although UTIs are often straightforward to treat, they are commonly caused by strains of bacteria increasingly resistant to traditional antibiotics, such as amoxicillin and ciprofloxacin. uUTIs affect millions in the US each year and primarily affect women.
Although UTIs are often straightforward to treat, they are commonly caused by strains of bacteria increasingly resistant to traditional antibiotics, such as amoxicillin and ciprofloxacin. uUTIs affect millions in the US each year and primarily affect women.
Macrophages are white blood cells that specialize in the detection, phagocytosis and destruction of bacteria and other harmful organisms. In other words, when fighting bacteria, the macrophages are programmed to be pro-inflammatory. However, when they are programmed to be anti-inflammatory, they can help decrease inflammation.
Not to mention that traditional antibiotics are designed to attack a broad spectrum of bacteria within the host’s body. These include the harmful bacterial pathogens that cause an infection, but also the beneficial bacteria which are part of the human microbiome and are essential for good health. About Micreos Pharmaceuticals.
Related: Pneumococcal Vaccination for Adults: Conversation with Vaccine Scientists Dr. Heather Platt and Dr. Ulrike Buchwald from Merck – Xtalks LifeScience Podcast Ep. 140 Other companies are also gearing up for their own adult-targeted pneumococcal vaccines.
They specifically found that consuming excess sugar early on in life leads to an increase in levels of Parabacteroides bacteria. Related: Research Shows How Gut Bacteria Can Help Fight Cancer. The researchers found that the cognitive impairments were associated with changes in the gut microbiota induced by high sugar levels.
The FDA’s decision was based on robust clinical data demonstrating Exblifep’s efficacy against antimicrobial resistance in gram-negative bacteria, particularly resistance associated with extended-spectrum beta-lactamases and ampC enzymes. What are cUTIs? However, Enterococcus spp. and Candida spp. The success rate was 79.1
Merck has scored US Food and Drug Administration (FDA) approval for its next-generation pneumonia vaccine Vaxneuvance that covers 15 different strains of the pneumococcal bacteria that causes the infection. Both next-gen shots offer enhanced protection against bacteria that can cause pneumonia, blood infections and meningitis.
Meanwhile, researchers advanced alternative therapies to combat antimicrobial resistance, targeting drug-resistant bacteria with novel antibiotics. This test, which enables the rapid detection of multi-drug-resistant tuberculosis, is expected to significantly improve early diagnosis rates globally.
CDIs typically develop after the use of antibiotics, which can wipe out the gut’s healthy bacteria. Seres’ microbiome drug SER-109 aims to restore the healthy bacteria via an oral capsule that contains a protective species of gut bacteria. Difficile infection (CDI).
The drug will have a boxed warning for increased risk of “life-threatening infections caused by encapsulated bacteria.” Given this, Fabhalta will be made available through a Risk Evaluation and Mitigation Strategy (REMS) program that requires vaccinations for encapsulated bacteria.
Integrases are used by viruses called bacteriophages to insert their genetic material into bacteria. “Just like CRISPR, these integrases come from the ongoing battle between bacteria and the viruses that infect them,” said Jonathan Gootenberg, also a McGovern Fellow. percent of these cells. ” The Future of PASTE.
difficile as certain antibiotics can disrupt the balance of bacteria in the gut, allowing bacteria like C. While Rebyota is the first of its kind pharmaceutical therapy, the concept of healing the gut via fecal matter-derived bacteria is not new. The use of certain antibiotics can contribute to infection caused by C.
It identifies bacteria using both genotypic and phenotypic assessments within 1.5 Empirical treatment usually gives two to three antibiotics at the same time to suppress unknown bacteria.”. fAST: Automated Bacteria Identification and Multiple Antibiotics Combination Test.
Owing to their size, they can be grown in bacteria as opposed to larger animal or human cells, making them easier and cheaper to produce. These regions play a crucial role in the detection of antigens on viruses, bacteria and other pathogens. Several groups have been researching nanobodies as treatment options for COVID-19.
20, 2020 /PRNewswire/ — Caris LifeSciences® , a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Winship Cancer Institute of Emory University (Winship) has joined Caris’ Precision Oncology Alliance (The Alliance/POA). .
Egorov told Xtalks that, “many studies being carried out right now show that one of the major ways that people get infected with COVID or any other virus or bacteria is not by sharing the bacteria [directly] by sneezing or coughing, but by [touching surfaces], holding hands and then rubbing the nose and eyes.
The autoantibodies do not fight actual infection or bacteria, but rather the normal tissue in the body. In those affected by lupus, autoreactive B cells (those that react against the body), remain in the body long after the “threat” to the immune system is gone. When this behaviour is prolonged, it results in inflammation.
Also important are the environmental changes that take place in the lung tissue during infection with SARS-CoV-2; the buildup of fluid and pus in pulmonary alveoli can provide a hospitable breeding ground for pathogenic bacteria. This is consistent with autopsy reports from previous pandemics, including the influenza pandemic of 1918.
Tapinarof was discovered as an outcome of investigations into the secondary metabolites of Photorhabdus luminescens, a bioluminescent, Gram-negative bacteria. There is 10 mg of tapinarof per gram of Vtama cream. XTALKS WEBINAR: All Means All: The Road to Inclusivity in Clinical Trials.
It has long been known that mothers greatly influence the development of the growing fetus by not only providing nutrients through the placenta, but also a growing list of biological elements including beneficial antibodies, gut bacteria and now, allergies.
Osteomyelitis is a bone infection caused by fungi or bacteria. BONESUPPORT received market authorization from the FDA for Cerament G, the first and only bone graft with antibiotic elution that is approved for the US market.
By focusing on the removal of excess bacteria, biofilm and bacterial toxins — the chief culprits behind eyelid symptoms — BlephEx presents a potent solution for those looking for symptom relief. Beyond this cleanser, the FDA has endorsed an in-office procedure named BlephEx.
The bacteria usually enter the body through wounds, but infection can also occur through contaminated meat or inhalation of spores. Anthrax is a rare, yet severe disease caused by the bacterium B. anthracis , primarily affecting livestock and wild game.
FL OZ (9 mL) nasal spray bottles to be contaminated with the bacteria, Providencia rettgeri. California-based Green Pharmaceuticals Inc. is recalling the 2372/21222 lot of their SnoreStop NasoSpray bottles. The US Food and Drug Administration (FDA) found the 0.3
As individuals get older, it becomes just as critical for them to keep up with required vaccinations to help protect against illnesses that can become life threatening as the immune system becomes weaker with age.
Research suggests that some gut bacteria can increase levels of ?-synuclein In the lifescience industry, so much can change in a short period of time. synuclein in the brain through the production of amyloids.
Lilly said it discovered some products claiming to be compounded tirzepatide medicines that contained bacteria, high impurity levels, different chemical structures and different colors than Mounjaro or Zepbound. “In In at least one instance, the product was nothing more than sugar alcohol,” said Lilly.
Her cryo-electron microscopy studies include analysis of nuclear peripheries and the machinery of gene expression in bacteria. Innovative solutions such as those developed by Dr. Zitnik are essential for dealing with the massive amounts of data and their complexity in medicine and lifesciences. The Otto Bayer Award.
.” In the new study, Ghosh and colleagues replaced the first and last steps in preclinical drug discovery with two novel approaches developed within the UC San Diego Institute for Network Medicine (iNetMed), which unites several research disciplines to develop new solutions to advance lifesciences and technology and enhance human health.
It may be caused by the immune system being triggered by a virus or bacteria that results in an atypical immune response, or genetics play a role in disease development as it is more common in people whose immediate family members have Crohn’s disease. These symptoms often lead to patients requiring urgent medical care.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content